HomeHealth articlesdiabetes and its liver related hepatic complicationsWhat Is the Correlation Between Diabetes and Liver Disease?

Liver Disease in Diabetes - Understanding the Association

Verified dataVerified data
0

5 min read

Share

Diabetes mellitus (DM) is a risk factor for the advancement of different chronic liver disorders (CLD) and is linked to increased mortality.

Medically reviewed by

Dr. Kaushal Bhavsar

Published At April 10, 2024
Reviewed AtApril 10, 2024

Introduction

A strong correlation exists between diabetes and liver damage. In certain instances, the presence of diabetes may result in the gradual development of liver fibrosis (fibrosis or thickening of the tissue), ultimately culminating in the manifestation of cirrhosis (many things can hurt the liver over time, causing scarring and eventually liver failure), a form of hepatic impairment. Diabetes mellitus has been found to accelerate the advancement of hepatic disorders. Moreover, evidence suggests that the presence of a liver illness may be a contributing factor in the development of diabetes.

What Is the Correlation Between Diabetes and Liver Disease?

Diabetes is a collection of medical conditions characterized by insufficient insulin production by the pancreas or inadequate utilization of the insulin produced by the body. Insulin is responsible for regulating blood glucose levels.

  • It has the potential to result in a medical state commonly referred to as hyperglycemia, characterized by elevated glucose levels in the bloodstream.

  • If left uncontrolled, chronically elevated blood glucose levels can significantly harm nerves, blood vessels, tissues, and organs throughout the body.

  • The liver is among the organs susceptible to these consequences. Over a prolonged period, the liver's capacity to effectively eliminate toxins from the bloodstream or regulate blood glucose levels might be compromised, leading to chronic liver disease (CLD).

  • The liver damage associated with chronic liver disease (CLD) is predominantly characterized by its irreversible nature.

  • A causal association exists between diabetes and liver disease, as chronic liver disease (CLD) can contribute to the onset of type 2 diabetes, which is mostly influenced by lifestyle variables such as nutrition and obesity.

What Are the Biological Processes That Describe the Association Among Diabetes and Liver Disease?

The liver might experience significant effects from hyperglycemia when diabetes is inadequately managed.

  • The liver is particularly susceptible to damage due to its dual function of glucose storage and synthesis, which is contingent upon the body's metabolic demands.

  • In typical conditions, blood sugar metabolism leads to the production of harmful byproducts called free radicals, which have the potential to damage the body. However, the presence of specific nutrients called antioxidants can effectively regulate these free radicals.

  • Elevated blood glucose levels can lead to an imbalance between free radicals and antioxidants, initiating cellular damage known as oxidative stress. Oxidative stress, in turn, initiates an inflammatory response that can lead to hepatic alterations over a prolonged period.

  • Diabetes has negative consequences that can affect the liver due to its role in glycogen storage inside the human body. Consequently, elevated blood glucose levels are associated with increased quantities of free radicals, leading to heightened oxidative stress.

What Are the Distinct Stages of Liver Damage Progression Arising From Diabetes?

The progression of liver damage resulting from diabetes occurs in distinct stages.

  • Metabolic Dysfunction-Associated Steatotic Liver Disease: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a pathological state characterized by fat accumulation within the liver, typically presenting without prominent clinical manifestations. MASLD, was previously referred to as nonalcoholic fatty liver disease (NAFLD).

  • Metabolic Dysfunction-Associated Steatohepatitis: Metabolic dysfunction-associated steatohepatitis (MASH) represents an advanced manifestation of metabolic dysfunction-associated fatty liver disease (MASLD), characterized by the initiation of fibrosis, a process involving the formation of scar tissue due to inflammation. MASH, previously referred to as nonalcoholic steatohepatitis (NASH).

  • Cirrhosis: Cirrhosis is a pathological condition in which fibrosis impedes the liver's functionality, resulting in either partial compensation (compensated cirrhosis) or complete decompensation (decompensated cirrhosis).

  • Hepatocellular Carcinoma: Hepatocellular carcinoma (HCC) is a prevalent kind of liver cancer that exhibits a higher incidence among those with diabetes, with rates reaching up to thrice compared to the general population.

  • Acute Liver Failure: Acute liver failure refers to the state in which the liver ceases to perform its normal functions as a result of cirrhosis or hepatocellular carcinoma (HCC). The condition is a critical medical situation that, if left untreated, can result in the collapse of multiple bodily systems and ultimately lead to mortality.

Individuals with liver disease caused by diabetes may exhibit varying rates of progression, with some reaching a specific stage and experiencing no further advancement. In contrast, others may ultimately develop end-stage illness. Individuals who exhibit inadequate management or lack of diabetes treatment are more susceptible to disease development.

What Are the Underlying Mechanisms That Contribute to the Relationship Between Liver Disease and Diabetes?

Diabetes has been observed to potentially induce chronic liver disease (CLD) by the prolonged exposure of the liver to inflammatory processes and fibrosis. Conversely, there exists substantiating data suggesting that CLD may contribute to the development of diabetes by inducing insulin resistance. Hepatic cells exhibit impaired responsiveness to insulin, resulting in a diminished capacity to effectively uptake glucose as per their physiological function.

  • The liver plays a significant role in regulating blood glucose levels through glucose absorption and release as needed. Insulin is the signaling molecule responsible for guiding hepatic cells to facilitate glucose uptake and subsequent storage.

  • Chronic liver disease (CLD) can induce a state of insulin resistance in liver cells, rendering them less susceptible to the physiological effects of insulin. Consequently, the liver, muscles, and other bodily tissues reduce their uptake of glucose. As a reaction, the pancreas secretes a greater amount of insulin to enhance the absorption of glucose by cells.

  • Over time, however, insulin resistance may lead to a gradual deterioration of pancreatic cells, resulting in an insufficient production of insulin to counterbalance this physiological condition. The outcome entails elevated blood glucose levels, which eventually lead to the development of prediabetes or type 2 diabetes.

What Are the Potential Risks Associated With the Condition?

CLD and diabetes are chronic disorders that worsen over time. Untreated diabetes increases liver disease risk, while liver disease increases diabetes risk. Advanced diabetes or CLD increases the chance of comorbidity.

  • Type 2 diabetes is a medical condition that typically manifests in individuals who are older than 45 years of age.

  • The individual with obesity.

  • Physical inactivity refers to engaging in insufficient or inadequate levels of physical activity.

  • The individual possesses a familial predisposition to diabetes.

  • The individual is experiencing a condition known as MASLD.

  • The habit of smoking.

  • Excessive consumption of alcohol.

  • Hepatitis B and C.

  • Suffering from type 2 diabetes.

What Are the Different Methods for Treating Diabetes and Liver Disease?

Both diabetes and chronic liver disease cannot be cured, but both can be controlled with medicine and a lifestyle change. The disease can be slowed down through these treatments, and long-term consequences that affect the kidneys, heart, and liver can be avoided.

  • Lifestyle Modifications- The therapy of diabetes and liver disease is well known to depend on simple lifestyle modifications such as increased exercise, a nutritious diet, quitting smoking, and abstaining from alcohol.

  • Medications- Drugs are frequently administered to maintain improved blood sugar control when diabetes and liver disease coexist. This lessens oxidative stress and prevents the liver from suffering further harm. When cirrhosis is present, the primary therapeutic approaches are dietary salt reduction and the administration of diuretics to mitigate the accumulation of abdominal fluid, commonly referred to as ascites. In instances of significant severity, it may be necessary to undergo a procedure wherein the accumulation of fluid within the abdominal cavity is alleviated through the utilization of a tube.

  • Targeted Therapy- Treatment options for liver cancer encompass various modalities, such as radiation therapy, ablation therapy involving the insertion of a probe or needle into the tumor to induce cell death, targeted therapy utilizing drugs that disrupt essential cancer growth factors, immunotherapy that harnesses the immune system or its components to combat cancer, resection surgery, or liver transplantation.

Conclusion

There exists a significant association between diabetes and chronic liver disease (CLD). One potential consequence of unregulated diabetes is the development of metabolic dysfunction-associated steatotic liver disease (MASLD), cirrhosis, and liver cancer, as it can induce alterations in liver function. Conversely, chronic liver disease (CLD) has the potential to reduce the sensitivity of liver cells to insulin, hence playing a role in the development of type 2 diabetes. Determining the causal relationship between two variables might pose challenges in discerning the cause and the effect.

Individuals diagnosed with diabetes and chronic liver disease (CLD) are typically subjected to a comprehensive treatment approach that encompasses both modifications in lifestyle and the administration of pharmaceutical interventions. The primary objective of this combined therapeutic strategy is to regulate and optimize blood glucose levels effectively. The management of diabetes reduces the burden on the liver, conserving its functionality and decelerating the progression of the illness.

Source Article IclonSourcesSource Article Arrow
Dr. Kaushal Bhavsar
Dr. Kaushal Bhavsar

Pulmonology (Asthma Doctors)

Tags:

diabetes and its liver related hepatic complications
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

diabetes and its liver related hepatic complications

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy